GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » 5-Year Dividend Growth Rate

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) 5-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co 5-Year Dividend Growth Rate?

Hunan Er-Kang Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was 44.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hunan Er-Kang Pharmaceutical Co was 56.70% per year. The lowest was -41.50% per year. And the median was 4.75% per year.

Hunan Er-Kang Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Hunan Er-Kang Pharmaceutical Co's Dividend Yield % is 1.15%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Er-Kang Pharmaceutical Co's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's 5-Year Dividend Growth Rate falls into.



Hunan Er-Kang Pharmaceutical Co 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Hunan Er-Kang Pharmaceutical Co  (SZSE:300267) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Hunan Er-Kang Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.001
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Hunan Er-Kang Pharmaceutical Co was 0.25. The lowest was 0.04. And the median was 0.11.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Hunan Er-Kang Pharmaceutical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.0300002023-06-092023-06-082023-06-09Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Hunan Er-Kang Pharmaceutical Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.03/2.61
=1.15 %

Current Share Price is ¥2.61.
Hunan Er-Kang Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.03.

During the past 13 years, the highest Dividend Yield of Hunan Er-Kang Pharmaceutical Co was 1.69%. The lowest was 0.11%. And the median was 0.32%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Er-Kang Pharmaceutical Co 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Business Description

Traded in Other Exchanges
N/A
Address
Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331
Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Headlines

No Headlines